ENDRA Life Sciences (NDRA) Receivables - Net (2017 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly Receivables - Net of $12275.0 for Q3 2018, up 4.29% quarter-over-quarter from $11770.0 in Q2 2018.

ENDRA Life Sciences (NDRA) Receivables - Net (2017 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Receivables - Net for 2 consecutive years, with $12275.0 the latest figure, recorded in Q3 2018.

In Q3 2018, Receivables - Net changed N/A year-over-year to $12275.0; the TTM figure through Sep 2018 stood at $12275.0 (changed N/A YoY), while the FY2017 annual figure was $6850.0, changed N/A from the prior year.
Receivables - Net rose to $12275.0 in Q3 2018 per NDRA's latest filing, from $11770.0 in the prior quarter.
Across five years, Receivables - Net topped out at $12275.0 in Q3 2018 and bottomed at $6850.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	ENDRA Life Sciences	7.16 Mn	1.62 Mn	-

Download Data